avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tgif1
|
ENSMUSG00000047407.11 | TGFB-induced factor homeobox 1 |
Meis3
|
ENSMUSG00000041420.12 | Meis homeobox 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Meis3 | mm10_v2_chr7_+_16175275_16175438 | -0.82 | 1.4e-09 | Click! |
Tgif1 | mm10_v2_chr17_-_70853482_70853546 | -0.67 | 8.7e-06 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_97417730 | 14.01 |
ENSMUST00000043077.7
|
Thrsp
|
thyroid hormone responsive |
chr19_+_39287074 | 12.31 |
ENSMUST00000003137.8
|
Cyp2c29
|
cytochrome P450, family 2, subfamily c, polypeptide 29 |
chr11_-_5950018 | 9.31 |
ENSMUST00000102920.3
|
Gck
|
glucokinase |
chr2_+_155517948 | 8.59 |
ENSMUST00000029135.8
ENSMUST00000065973.2 ENSMUST00000103142.5 |
Acss2
|
acyl-CoA synthetase short-chain family member 2 |
chr5_-_87337165 | 8.53 |
ENSMUST00000031195.2
|
Ugt2a3
|
UDP glucuronosyltransferase 2 family, polypeptide A3 |
chr7_-_30924169 | 8.06 |
ENSMUST00000074671.6
|
Hamp2
|
hepcidin antimicrobial peptide 2 |
chr8_+_105083753 | 7.39 |
ENSMUST00000093221.6
ENSMUST00000074403.6 |
Ces3b
|
carboxylesterase 3B |
chr15_-_76126538 | 7.16 |
ENSMUST00000054022.5
ENSMUST00000089654.3 |
BC024139
|
cDNA sequence BC024139 |
chrX_+_10252361 | 7.06 |
ENSMUST00000115528.2
|
Otc
|
ornithine transcarbamylase |
chrX_+_10252305 | 6.74 |
ENSMUST00000049910.6
|
Otc
|
ornithine transcarbamylase |
chr18_-_74961252 | 6.24 |
ENSMUST00000066532.4
|
Lipg
|
lipase, endothelial |
chr15_-_60921270 | 6.16 |
ENSMUST00000096418.3
|
A1bg
|
alpha-1-B glycoprotein |
chr8_+_107150621 | 5.35 |
ENSMUST00000034400.3
|
Cyb5b
|
cytochrome b5 type B |
chr7_-_46742979 | 5.10 |
ENSMUST00000128088.1
|
Saa1
|
serum amyloid A 1 |
chr3_-_81975742 | 4.85 |
ENSMUST00000029645.8
|
Tdo2
|
tryptophan 2,3-dioxygenase |
chr9_+_74953053 | 4.73 |
ENSMUST00000170846.1
|
Fam214a
|
family with sequence similarity 214, member A |
chr2_+_102706356 | 4.67 |
ENSMUST00000123759.1
ENSMUST00000111212.1 ENSMUST00000005220.4 |
Slc1a2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr10_-_24101951 | 4.64 |
ENSMUST00000170267.1
|
Taar8c
|
trace amine-associated receptor 8C |
chr15_+_6445320 | 4.60 |
ENSMUST00000022749.9
|
C9
|
complement component 9 |
chr19_-_7966000 | 4.42 |
ENSMUST00000182102.1
ENSMUST00000075619.4 |
Slc22a27
|
solute carrier family 22, member 27 |
chr4_-_82705735 | 4.35 |
ENSMUST00000155821.1
|
Nfib
|
nuclear factor I/B |
chr11_+_77518566 | 4.24 |
ENSMUST00000147386.1
|
Abhd15
|
abhydrolase domain containing 15 |
chr1_+_130826676 | 4.19 |
ENSMUST00000027675.7
|
Pigr
|
polymeric immunoglobulin receptor |
chr15_+_10177623 | 4.19 |
ENSMUST00000124470.1
|
Prlr
|
prolactin receptor |
chr1_-_150466165 | 4.08 |
ENSMUST00000162367.1
ENSMUST00000161611.1 ENSMUST00000161320.1 ENSMUST00000159035.1 |
Prg4
|
proteoglycan 4 (megakaryocyte stimulating factor, articular superficial zone protein) |
chr6_-_85869128 | 4.00 |
ENSMUST00000045008.7
|
Cml2
|
camello-like 2 |
chr15_+_10215955 | 3.88 |
ENSMUST00000130720.1
|
Prlr
|
prolactin receptor |
chr10_+_87860030 | 3.84 |
ENSMUST00000062862.6
|
Igf1
|
insulin-like growth factor 1 |
chr1_-_180195981 | 3.82 |
ENSMUST00000027766.6
ENSMUST00000161814.1 |
Adck3
|
aarF domain containing kinase 3 |
chr19_-_8218832 | 3.81 |
ENSMUST00000113298.2
|
Slc22a29
|
solute carrier family 22. member 29 |
chr1_+_167618246 | 3.74 |
ENSMUST00000111380.1
|
Rxrg
|
retinoid X receptor gamma |
chr2_-_86347764 | 3.67 |
ENSMUST00000099894.2
|
Olfr1055
|
olfactory receptor 1055 |
chr11_-_11890368 | 3.65 |
ENSMUST00000155690.1
|
Ddc
|
dopa decarboxylase |
chr2_-_103485068 | 3.61 |
ENSMUST00000111168.3
|
Cat
|
catalase |
chr7_+_46751832 | 3.61 |
ENSMUST00000075982.2
|
Saa2
|
serum amyloid A 2 |
chr4_-_155345696 | 3.58 |
ENSMUST00000103178.4
|
Prkcz
|
protein kinase C, zeta |
chr15_+_9279829 | 3.53 |
ENSMUST00000022861.8
|
Ugt3a1
|
UDP glycosyltransferases 3 family, polypeptide A1 |
chr19_+_3986564 | 3.52 |
ENSMUST00000054030.7
|
Acy3
|
aspartoacylase (aminoacylase) 3 |
chr19_-_8405060 | 3.45 |
ENSMUST00000064507.5
ENSMUST00000120540.1 ENSMUST00000096269.4 |
Slc22a30
|
solute carrier family 22, member 30 |
chr17_+_24804312 | 3.40 |
ENSMUST00000024972.5
|
Meiob
|
meiosis specific with OB domains |
chr10_-_81291227 | 3.35 |
ENSMUST00000045744.6
|
Tjp3
|
tight junction protein 3 |
chr10_+_116301374 | 3.33 |
ENSMUST00000092167.5
|
Ptprb
|
protein tyrosine phosphatase, receptor type, B |
chr19_-_7802578 | 3.27 |
ENSMUST00000120522.1
ENSMUST00000065634.7 |
Slc22a26
|
solute carrier family 22 (organic cation transporter), member 26 |
chr11_+_98348404 | 3.26 |
ENSMUST00000078694.6
|
Ppp1r1b
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
chr8_-_67974567 | 3.26 |
ENSMUST00000098696.3
ENSMUST00000038959.9 ENSMUST00000093469.4 |
Psd3
|
pleckstrin and Sec7 domain containing 3 |
chr7_-_99695809 | 3.24 |
ENSMUST00000107086.2
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr1_-_121327672 | 3.22 |
ENSMUST00000159085.1
ENSMUST00000159125.1 ENSMUST00000161818.1 |
Insig2
|
insulin induced gene 2 |
chr8_-_5105232 | 3.17 |
ENSMUST00000023835.1
|
Slc10a2
|
solute carrier family 10, member 2 |
chr8_+_45658666 | 3.07 |
ENSMUST00000134675.1
ENSMUST00000139869.1 ENSMUST00000126067.1 |
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr3_+_94377505 | 3.07 |
ENSMUST00000098877.2
|
Rorc
|
RAR-related orphan receptor gamma |
chr2_+_71981184 | 3.07 |
ENSMUST00000090826.5
ENSMUST00000102698.3 |
Rapgef4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chrX_+_140664565 | 3.05 |
ENSMUST00000128809.1
|
Mid2
|
midline 2 |
chr10_+_87859593 | 3.02 |
ENSMUST00000126490.1
|
Igf1
|
insulin-like growth factor 1 |
chr2_+_162987330 | 2.96 |
ENSMUST00000018012.7
|
Sgk2
|
serum/glucocorticoid regulated kinase 2 |
chr9_+_108692116 | 2.95 |
ENSMUST00000035220.6
|
Prkar2a
|
protein kinase, cAMP dependent regulatory, type II alpha |
chr19_+_38481057 | 2.94 |
ENSMUST00000182481.1
|
Plce1
|
phospholipase C, epsilon 1 |
chrX_-_113185485 | 2.94 |
ENSMUST00000026607.8
ENSMUST00000113388.2 |
Chm
|
choroidermia |
chr15_-_58076456 | 2.93 |
ENSMUST00000070143.6
ENSMUST00000110168.1 |
Zhx1
|
zinc fingers and homeoboxes 1 |
chr4_-_119383732 | 2.93 |
ENSMUST00000044781.2
ENSMUST00000084307.3 |
Ccdc30
|
coiled-coil domain containing 30 |
chr7_-_14492926 | 2.92 |
ENSMUST00000108524.3
|
Sult2a7
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 7 |
chr19_-_20727533 | 2.88 |
ENSMUST00000025656.3
|
Aldh1a7
|
aldehyde dehydrogenase family 1, subfamily A7 |
chr11_-_11890394 | 2.86 |
ENSMUST00000109659.2
|
Ddc
|
dopa decarboxylase |
chr11_-_84167466 | 2.82 |
ENSMUST00000050771.7
|
Gm11437
|
predicted gene 11437 |
chr11_-_72795801 | 2.82 |
ENSMUST00000079681.5
|
Cyb5d2
|
cytochrome b5 domain containing 2 |
chr10_+_128254131 | 2.78 |
ENSMUST00000060782.3
|
Apon
|
apolipoprotein N |
chr1_-_121327734 | 2.71 |
ENSMUST00000160968.1
ENSMUST00000162582.1 |
Insig2
|
insulin induced gene 2 |
chr4_+_148130883 | 2.68 |
ENSMUST00000084129.2
|
Mad2l2
|
MAD2 mitotic arrest deficient-like 2 |
chr10_+_79890853 | 2.66 |
ENSMUST00000061653.7
|
Cfd
|
complement factor D (adipsin) |
chr6_+_125320633 | 2.65 |
ENSMUST00000176655.1
ENSMUST00000176110.1 |
Scnn1a
|
sodium channel, nonvoltage-gated 1 alpha |
chr2_-_67433181 | 2.64 |
ENSMUST00000180773.1
|
Gm26727
|
predicted gene, 26727 |
chr15_+_44196135 | 2.64 |
ENSMUST00000038856.6
ENSMUST00000110289.3 |
Trhr
|
thyrotropin releasing hormone receptor |
chr7_+_49246131 | 2.63 |
ENSMUST00000064395.6
|
Nav2
|
neuron navigator 2 |
chr14_+_69171576 | 2.62 |
ENSMUST00000062437.8
|
Nkx2-6
|
NK2 homeobox 6 |
chr8_+_76899772 | 2.62 |
ENSMUST00000109913.2
|
Nr3c2
|
nuclear receptor subfamily 3, group C, member 2 |
chr1_+_187997835 | 2.61 |
ENSMUST00000110938.1
|
Esrrg
|
estrogen-related receptor gamma |
chrX_+_140664908 | 2.61 |
ENSMUST00000112990.1
ENSMUST00000112988.1 |
Mid2
|
midline 2 |
chr2_-_164857542 | 2.60 |
ENSMUST00000109316.1
ENSMUST00000156255.1 ENSMUST00000128110.1 ENSMUST00000109317.3 |
Pltp
|
phospholipid transfer protein |
chr3_+_94377432 | 2.58 |
ENSMUST00000107292.1
|
Rorc
|
RAR-related orphan receptor gamma |
chr8_+_45658273 | 2.57 |
ENSMUST00000153798.1
|
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr17_+_43953191 | 2.57 |
ENSMUST00000044792.4
|
Rcan2
|
regulator of calcineurin 2 |
chr17_+_43952999 | 2.56 |
ENSMUST00000177857.1
|
Rcan2
|
regulator of calcineurin 2 |
chr6_+_88724489 | 2.56 |
ENSMUST00000113581.1
|
Mgll
|
monoglyceride lipase |
chr18_+_56432116 | 2.56 |
ENSMUST00000070166.5
|
Gramd3
|
GRAM domain containing 3 |
chr14_-_51922773 | 2.51 |
ENSMUST00000089771.2
|
Rnase13
|
ribonuclease, RNase A family, 13 (non-active) |
chr5_-_87092546 | 2.50 |
ENSMUST00000132667.1
ENSMUST00000145617.1 ENSMUST00000094649.4 |
Ugt2b36
|
UDP glucuronosyltransferase 2 family, polypeptide B36 |
chr13_-_24206281 | 2.49 |
ENSMUST00000123076.1
|
Lrrc16a
|
leucine rich repeat containing 16A |
chr10_+_87859255 | 2.46 |
ENSMUST00000105300.2
|
Igf1
|
insulin-like growth factor 1 |
chr7_+_140845562 | 2.45 |
ENSMUST00000035300.5
|
Scgb1c1
|
secretoglobin, family 1C, member 1 |
chr4_-_96664112 | 2.43 |
ENSMUST00000030299.7
|
Cyp2j5
|
cytochrome P450, family 2, subfamily j, polypeptide 5 |
chr7_-_25539845 | 2.43 |
ENSMUST00000066503.7
ENSMUST00000064862.6 |
Ceacam2
|
carcinoembryonic antigen-related cell adhesion molecule 2 |
chr6_-_85832082 | 2.43 |
ENSMUST00000032073.6
|
Nat8
|
N-acetyltransferase 8 (GCN5-related, putative) |
chr7_-_114562945 | 2.43 |
ENSMUST00000119712.1
ENSMUST00000032908.8 |
Cyp2r1
|
cytochrome P450, family 2, subfamily r, polypeptide 1 |
chr6_+_88724462 | 2.40 |
ENSMUST00000113582.1
|
Mgll
|
monoglyceride lipase |
chr17_-_12940317 | 2.40 |
ENSMUST00000160378.1
ENSMUST00000043923.5 |
Acat3
|
acetyl-Coenzyme A acetyltransferase 3 |
chr9_+_55326913 | 2.40 |
ENSMUST00000085754.3
ENSMUST00000034862.4 |
AI118078
|
expressed sequence AI118078 |
chr1_-_139781236 | 2.39 |
ENSMUST00000027612.8
ENSMUST00000111989.2 ENSMUST00000111986.2 |
Gm4788
|
predicted gene 4788 |
chr11_+_83746940 | 2.39 |
ENSMUST00000070832.2
|
1100001G20Rik
|
RIKEN cDNA 1100001G20 gene |
chr7_+_87246649 | 2.37 |
ENSMUST00000068829.5
ENSMUST00000032781.7 |
Nox4
|
NADPH oxidase 4 |
chr11_+_72435511 | 2.37 |
ENSMUST00000076443.3
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr2_+_72054598 | 2.37 |
ENSMUST00000028525.5
|
Rapgef4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr19_-_57182293 | 2.35 |
ENSMUST00000133369.1
|
Ablim1
|
actin-binding LIM protein 1 |
chr2_+_162987502 | 2.35 |
ENSMUST00000117123.1
|
Sgk2
|
serum/glucocorticoid regulated kinase 2 |
chr6_+_88724828 | 2.35 |
ENSMUST00000089449.2
|
Mgll
|
monoglyceride lipase |
chr6_-_138043411 | 2.34 |
ENSMUST00000111873.1
|
Slc15a5
|
solute carrier family 15, member 5 |
chr4_+_102254993 | 2.32 |
ENSMUST00000106908.2
|
Pde4b
|
phosphodiesterase 4B, cAMP specific |
chr10_+_87859062 | 2.31 |
ENSMUST00000095360.4
|
Igf1
|
insulin-like growth factor 1 |
chr11_+_72435565 | 2.31 |
ENSMUST00000100903.2
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr3_+_107631322 | 2.28 |
ENSMUST00000106703.1
|
Gm10961
|
predicted gene 10961 |
chr2_-_25461094 | 2.28 |
ENSMUST00000114261.2
|
BC029214
|
cDNA sequence BC029214 |
chr8_-_84800024 | 2.27 |
ENSMUST00000126806.1
ENSMUST00000076715.6 |
Nfix
|
nuclear factor I/X |
chr11_+_72435534 | 2.26 |
ENSMUST00000108499.1
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr7_-_25477607 | 2.26 |
ENSMUST00000098669.1
ENSMUST00000098668.1 ENSMUST00000098666.2 |
Ceacam1
|
carcinoembryonic antigen-related cell adhesion molecule 1 |
chr4_+_115411624 | 2.25 |
ENSMUST00000094887.3
|
Cyp4a12b
|
cytochrome P450, family 4, subfamily a, polypeptide 12B |
chr5_+_65131184 | 2.23 |
ENSMUST00000031089.5
ENSMUST00000101191.3 |
Klhl5
|
kelch-like 5 |
chr3_+_89459325 | 2.23 |
ENSMUST00000107410.1
|
Pmvk
|
phosphomevalonate kinase |
chr8_-_45382198 | 2.22 |
ENSMUST00000093526.6
|
Fam149a
|
family with sequence similarity 149, member A |
chr1_+_93235836 | 2.21 |
ENSMUST00000062202.7
|
Sned1
|
sushi, nidogen and EGF-like domains 1 |
chr8_+_104926237 | 2.20 |
ENSMUST00000034355.4
ENSMUST00000109410.2 |
Ces2e
|
carboxylesterase 2E |
chr6_+_88724667 | 2.18 |
ENSMUST00000163271.1
|
Mgll
|
monoglyceride lipase |
chr1_+_88095054 | 2.18 |
ENSMUST00000150634.1
ENSMUST00000058237.7 |
Ugt1a7c
|
UDP glucuronosyltransferase 1 family, polypeptide A7C |
chr7_-_48848023 | 2.17 |
ENSMUST00000032658.6
|
Csrp3
|
cysteine and glycine-rich protein 3 |
chr8_+_88697022 | 2.17 |
ENSMUST00000043526.8
|
Cyld
|
cylindromatosis (turban tumor syndrome) |
chr17_-_34305715 | 2.16 |
ENSMUST00000174074.1
|
Gm20513
|
predicted gene 20513 |
chr11_-_5915124 | 2.15 |
ENSMUST00000109823.2
ENSMUST00000109822.1 |
Gck
|
glucokinase |
chr7_-_45136102 | 2.14 |
ENSMUST00000125500.1
|
Flt3l
|
FMS-like tyrosine kinase 3 ligand |
chr2_-_25500613 | 2.13 |
ENSMUST00000040042.4
|
C8g
|
complement component 8, gamma polypeptide |
chr2_-_73386396 | 2.10 |
ENSMUST00000112044.1
ENSMUST00000112043.1 ENSMUST00000076463.5 |
Gpr155
|
G protein-coupled receptor 155 |
chr4_+_41760454 | 2.10 |
ENSMUST00000108040.1
|
Il11ra1
|
interleukin 11 receptor, alpha chain 1 |
chr6_-_85915604 | 2.09 |
ENSMUST00000174369.1
|
Cml1
|
camello-like 1 |
chr3_-_88425094 | 2.09 |
ENSMUST00000168755.1
ENSMUST00000057935.6 |
Slc25a44
|
solute carrier family 25, member 44 |
chr18_-_39490649 | 2.07 |
ENSMUST00000115567.1
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1 |
chr10_+_62920648 | 2.05 |
ENSMUST00000144459.1
|
Slc25a16
|
solute carrier family 25 (mitochondrial carrier, Graves disease autoantigen), member 16 |
chr15_+_23036449 | 2.05 |
ENSMUST00000164787.1
|
Cdh18
|
cadherin 18 |
chr16_+_13940630 | 2.05 |
ENSMUST00000141971.1
ENSMUST00000124947.1 ENSMUST00000023360.7 ENSMUST00000143697.1 |
Mpv17l
|
Mpv17 transgene, kidney disease mutant-like |
chr9_+_77921908 | 2.05 |
ENSMUST00000133757.1
|
Elovl5
|
ELOVL family member 5, elongation of long chain fatty acids (yeast) |
chr15_-_8519953 | 2.04 |
ENSMUST00000179217.1
|
Gm2310
|
predicted gene 2310 |
chr3_-_89393629 | 2.03 |
ENSMUST00000124783.1
ENSMUST00000126027.1 |
Zbtb7b
|
zinc finger and BTB domain containing 7B |
chr19_+_12633303 | 2.02 |
ENSMUST00000044976.5
|
Glyat
|
glycine-N-acyltransferase |
chr2_+_31887262 | 2.02 |
ENSMUST00000138325.1
ENSMUST00000028187.6 |
Lamc3
|
laminin gamma 3 |
chr8_+_45627709 | 2.01 |
ENSMUST00000134321.1
ENSMUST00000135336.1 |
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr7_-_45136056 | 2.01 |
ENSMUST00000130628.1
|
Flt3l
|
FMS-like tyrosine kinase 3 ligand |
chr8_-_117673682 | 2.01 |
ENSMUST00000173522.1
ENSMUST00000174450.1 |
Sdr42e1
|
short chain dehydrogenase/reductase family 42E, member 1 |
chr10_+_62920630 | 2.00 |
ENSMUST00000044977.3
|
Slc25a16
|
solute carrier family 25 (mitochondrial carrier, Graves disease autoantigen), member 16 |
chrX_-_60403947 | 2.00 |
ENSMUST00000033480.6
ENSMUST00000101527.2 |
Atp11c
|
ATPase, class VI, type 11C |
chr13_-_47043116 | 1.98 |
ENSMUST00000110118.1
ENSMUST00000124948.1 ENSMUST00000021806.3 ENSMUST00000136864.1 |
Tpmt
|
thiopurine methyltransferase |
chr5_-_51553896 | 1.98 |
ENSMUST00000132734.1
|
Ppargc1a
|
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
chr14_-_31640878 | 1.98 |
ENSMUST00000167066.1
ENSMUST00000127204.2 ENSMUST00000022437.8 |
Hacl1
|
2-hydroxyacyl-CoA lyase 1 |
chr19_+_12633507 | 1.97 |
ENSMUST00000119960.1
|
Glyat
|
glycine-N-acyltransferase |
chr13_-_92131494 | 1.97 |
ENSMUST00000099326.3
ENSMUST00000146492.1 |
Rasgrf2
|
RAS protein-specific guanine nucleotide-releasing factor 2 |
chr10_-_83337440 | 1.96 |
ENSMUST00000126617.1
|
Slc41a2
|
solute carrier family 41, member 2 |
chr2_-_160872552 | 1.95 |
ENSMUST00000103111.2
|
Zhx3
|
zinc fingers and homeoboxes 3 |
chr15_+_7129557 | 1.95 |
ENSMUST00000067190.5
ENSMUST00000164529.1 |
Lifr
|
leukemia inhibitory factor receptor |
chr8_-_41041828 | 1.95 |
ENSMUST00000051379.7
|
Mtus1
|
mitochondrial tumor suppressor 1 |
chr2_-_164857671 | 1.94 |
ENSMUST00000059954.7
|
Pltp
|
phospholipid transfer protein |
chr4_+_138967112 | 1.94 |
ENSMUST00000116094.2
|
Rnf186
|
ring finger protein 186 |
chr10_+_107271827 | 1.93 |
ENSMUST00000020057.8
ENSMUST00000105280.3 |
Lin7a
|
lin-7 homolog A (C. elegans) |
chr3_+_146597077 | 1.93 |
ENSMUST00000029837.7
ENSMUST00000121133.1 |
Uox
|
urate oxidase |
chr2_-_77519565 | 1.92 |
ENSMUST00000111830.2
|
Zfp385b
|
zinc finger protein 385B |
chr1_+_88087802 | 1.92 |
ENSMUST00000113139.1
|
Ugt1a8
|
UDP glucuronosyltransferase 1 family, polypeptide A8 |
chr5_+_137981512 | 1.92 |
ENSMUST00000035390.5
|
Azgp1
|
alpha-2-glycoprotein 1, zinc |
chr17_+_50509518 | 1.91 |
ENSMUST00000043938.6
|
Plcl2
|
phospholipase C-like 2 |
chr1_+_187997821 | 1.90 |
ENSMUST00000027906.6
|
Esrrg
|
estrogen-related receptor gamma |
chr7_-_126584578 | 1.90 |
ENSMUST00000150311.1
|
Cln3
|
ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) |
chrX_-_75843063 | 1.90 |
ENSMUST00000114057.1
|
Pls3
|
plastin 3 (T-isoform) |
chr19_+_26605106 | 1.89 |
ENSMUST00000025862.7
ENSMUST00000176030.1 |
Smarca2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
chr9_-_9239019 | 1.89 |
ENSMUST00000183182.1
|
Arhgap42
|
Rho GTPase activating protein 42 |
chr2_-_27246814 | 1.89 |
ENSMUST00000149733.1
|
Sardh
|
sarcosine dehydrogenase |
chr19_+_5878622 | 1.89 |
ENSMUST00000136833.1
ENSMUST00000141362.1 |
Slc25a45
|
solute carrier family 25, member 45 |
chr2_-_39065505 | 1.88 |
ENSMUST00000039165.8
|
Golga1
|
golgi autoantigen, golgin subfamily a, 1 |
chr2_+_43555321 | 1.88 |
ENSMUST00000028223.2
|
Kynu
|
kynureninase (L-kynurenine hydrolase) |
chr10_+_63024315 | 1.88 |
ENSMUST00000124784.1
|
Pbld2
|
phenazine biosynthesis-like protein domain containing 2 |
chr17_-_24209377 | 1.87 |
ENSMUST00000024931.4
|
Ntn3
|
netrin 3 |
chr3_+_89459118 | 1.86 |
ENSMUST00000029564.5
|
Pmvk
|
phosphomevalonate kinase |
chr11_-_50931612 | 1.84 |
ENSMUST00000109124.3
|
Zfp354b
|
zinc finger protein 354B |
chr6_+_115675983 | 1.84 |
ENSMUST00000068960.9
|
D830050J10Rik
|
RIKEN cDNA D830050J10 gene |
chr4_+_141239499 | 1.84 |
ENSMUST00000141834.2
|
Arhgef19
|
Rho guanine nucleotide exchange factor (GEF) 19 |
chr1_-_180195902 | 1.83 |
ENSMUST00000161746.1
|
Adck3
|
aarF domain containing kinase 3 |
chr7_+_131410601 | 1.83 |
ENSMUST00000015829.7
ENSMUST00000117518.1 |
Acadsb
|
acyl-Coenzyme A dehydrogenase, short/branched chain |
chr6_+_125321205 | 1.82 |
ENSMUST00000176365.1
|
Scnn1a
|
sodium channel, nonvoltage-gated 1 alpha |
chrX_+_59999436 | 1.82 |
ENSMUST00000033477.4
|
F9
|
coagulation factor IX |
chr7_-_101845300 | 1.81 |
ENSMUST00000094141.5
|
Folr2
|
folate receptor 2 (fetal) |
chr4_-_84546284 | 1.81 |
ENSMUST00000177040.1
|
Bnc2
|
basonuclin 2 |
chr13_+_46669517 | 1.81 |
ENSMUST00000099547.3
|
C78339
|
expressed sequence C78339 |
chr5_+_92137896 | 1.80 |
ENSMUST00000031355.6
|
Uso1
|
USO1 vesicle docking factor |
chr11_+_99873389 | 1.79 |
ENSMUST00000093936.3
|
Krtap9-1
|
keratin associated protein 9-1 |
chr15_-_100599864 | 1.79 |
ENSMUST00000177247.2
ENSMUST00000177505.2 |
Pou6f1
|
POU domain, class 6, transcription factor 1 |
chrX_+_57212110 | 1.79 |
ENSMUST00000033466.1
|
Cd40lg
|
CD40 ligand |
chr19_+_32757497 | 1.77 |
ENSMUST00000013807.7
|
Pten
|
phosphatase and tensin homolog |
chr14_+_123659971 | 1.76 |
ENSMUST00000049681.7
|
Itgbl1
|
integrin, beta-like 1 |
chr8_+_85492568 | 1.76 |
ENSMUST00000034136.5
|
Gpt2
|
glutamic pyruvate transaminase (alanine aminotransferase) 2 |
chr2_+_43555342 | 1.76 |
ENSMUST00000112826.1
ENSMUST00000050511.6 |
Kynu
|
kynureninase (L-kynurenine hydrolase) |
chr1_-_136960427 | 1.75 |
ENSMUST00000027649.7
|
Nr5a2
|
nuclear receptor subfamily 5, group A, member 2 |
chr12_+_104115970 | 1.74 |
ENSMUST00000021496.7
|
Serpina3a
|
serine (or cysteine) peptidase inhibitor, clade A, member 3A |
chr1_-_162898484 | 1.72 |
ENSMUST00000143123.1
|
Fmo2
|
flavin containing monooxygenase 2 |
chr8_+_109990430 | 1.72 |
ENSMUST00000001720.7
ENSMUST00000143741.1 |
Tat
|
tyrosine aminotransferase |
chr2_-_103485138 | 1.72 |
ENSMUST00000028610.3
|
Cat
|
catalase |
chr9_-_9239052 | 1.71 |
ENSMUST00000093893.5
|
Arhgap42
|
Rho GTPase activating protein 42 |
chr6_+_125321409 | 1.71 |
ENSMUST00000176442.1
ENSMUST00000177329.1 |
Scnn1a
|
sodium channel, nonvoltage-gated 1 alpha |
chrX_+_139800795 | 1.71 |
ENSMUST00000054889.3
|
Cldn2
|
claudin 2 |
chr9_+_59589288 | 1.71 |
ENSMUST00000121266.1
ENSMUST00000118164.1 |
Celf6
|
CUGBP, Elav-like family member 6 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 13.8 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
2.8 | 8.5 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
2.5 | 12.6 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
2.2 | 8.6 | GO:0034757 | negative regulation of iron ion transport(GO:0034757) negative regulation of iron ion transmembrane transport(GO:0034760) |
1.9 | 11.6 | GO:1904075 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
1.8 | 7.3 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of lipoprotein particle clearance(GO:0010986) |
1.7 | 10.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
1.6 | 6.4 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
1.5 | 10.3 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
1.3 | 8.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.3 | 4.0 | GO:0006657 | CDP-choline pathway(GO:0006657) |
1.2 | 3.6 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
1.1 | 4.4 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
1.1 | 4.4 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
1.1 | 4.3 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
1.1 | 4.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.0 | 4.2 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
1.0 | 17.5 | GO:0052695 | cellular glucuronidation(GO:0052695) |
1.0 | 13.9 | GO:0015747 | urate transport(GO:0015747) |
1.0 | 4.9 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.9 | 4.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.9 | 3.6 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.9 | 5.4 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
0.9 | 3.6 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.9 | 6.3 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.9 | 2.6 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.8 | 11.9 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.8 | 2.4 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.8 | 3.2 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
0.8 | 2.4 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) |
0.8 | 2.4 | GO:0070342 | brown fat cell proliferation(GO:0070342) regulation of brown fat cell proliferation(GO:0070347) |
0.8 | 3.2 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.8 | 2.3 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.7 | 3.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.7 | 2.2 | GO:1903918 | regulation of actin filament severing(GO:1903918) negative regulation of actin filament severing(GO:1903919) |
0.7 | 3.5 | GO:0021564 | vagus nerve development(GO:0021564) |
0.7 | 2.1 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
0.7 | 2.0 | GO:0072343 | pancreatic stellate cell proliferation(GO:0072343) regulation of pancreatic stellate cell proliferation(GO:2000229) |
0.7 | 2.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.6 | 3.2 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.6 | 1.9 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.6 | 2.5 | GO:0001887 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
0.6 | 1.8 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.6 | 1.2 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
0.6 | 1.8 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
0.6 | 1.8 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.6 | 2.9 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.6 | 6.3 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
0.6 | 2.3 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.6 | 4.0 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.6 | 2.3 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.6 | 18.2 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.6 | 5.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.6 | 5.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.5 | 2.2 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.5 | 3.8 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.5 | 2.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.5 | 1.6 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.5 | 2.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.5 | 0.5 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.5 | 2.5 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
0.5 | 2.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.5 | 1.0 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.5 | 1.5 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.5 | 2.9 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.5 | 1.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.5 | 5.8 | GO:0009650 | UV protection(GO:0009650) |
0.5 | 2.9 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.5 | 3.3 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.5 | 1.4 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.5 | 1.4 | GO:2000040 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.5 | 2.3 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.5 | 1.4 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
0.5 | 1.4 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.4 | 1.3 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.4 | 1.8 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.4 | 1.3 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.4 | 8.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.4 | 1.3 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.4 | 0.4 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.4 | 1.3 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.4 | 1.3 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
0.4 | 3.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.4 | 2.9 | GO:0015862 | uridine transport(GO:0015862) |
0.4 | 1.2 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.4 | 2.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.4 | 1.6 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.4 | 2.0 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.4 | 1.2 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.4 | 1.6 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.4 | 1.6 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.4 | 1.6 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.4 | 12.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.4 | 1.2 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.4 | 1.9 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.4 | 1.2 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.4 | 1.5 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.4 | 2.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.4 | 1.4 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.4 | 0.7 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.4 | 0.4 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
0.3 | 1.0 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.3 | 2.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.3 | 2.8 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.3 | 1.0 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.3 | 1.0 | GO:0035603 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) |
0.3 | 0.3 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.3 | 1.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.3 | 3.1 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.3 | 4.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.3 | 1.4 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.3 | 3.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.3 | 1.4 | GO:0048294 | regulation of memory T cell differentiation(GO:0043380) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.3 | 2.9 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.3 | 3.2 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.3 | 1.3 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.3 | 1.0 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.3 | 1.3 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.3 | 0.3 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
0.3 | 1.5 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.3 | 4.0 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.3 | 0.9 | GO:0061552 | vestibulocochlear nerve structural organization(GO:0021649) cell migration involved in vasculogenesis(GO:0035441) neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) ganglion morphogenesis(GO:0061552) dorsal root ganglion morphogenesis(GO:1904835) |
0.3 | 1.8 | GO:0071484 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
0.3 | 3.5 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.3 | 2.3 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.3 | 0.9 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.3 | 1.7 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 1.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.3 | 1.4 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.3 | 1.7 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.3 | 0.6 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.3 | 1.1 | GO:0090126 | protein complex assembly involved in synapse maturation(GO:0090126) |
0.3 | 0.6 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.3 | 1.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 2.4 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.3 | 5.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.3 | 0.8 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
0.3 | 3.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.3 | 1.1 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.3 | 0.5 | GO:0031038 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.3 | 0.8 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.3 | 1.6 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.3 | 1.6 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.3 | 5.0 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.3 | 2.3 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.3 | 7.4 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 2.8 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.3 | 0.8 | GO:0042197 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
0.2 | 1.7 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.2 | 0.5 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.2 | 0.5 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.2 | 1.0 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.2 | 0.7 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.2 | 1.5 | GO:0015867 | ATP transport(GO:0015867) |
0.2 | 6.8 | GO:0080184 | response to phenylpropanoid(GO:0080184) |
0.2 | 1.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 0.9 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.2 | 3.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 0.5 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.2 | 0.9 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 0.9 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.2 | 0.5 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 0.2 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.2 | 2.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 1.8 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.2 | 0.9 | GO:1903027 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.2 | 0.7 | GO:0006227 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.2 | 2.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 1.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 3.8 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.2 | 0.9 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.2 | 0.7 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.2 | 0.4 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) regulation of vitamin A metabolic process(GO:1901738) |
0.2 | 1.1 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.2 | 0.2 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.2 | 0.9 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.6 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.2 | 9.0 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.6 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.2 | 0.6 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.2 | 1.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 1.0 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.2 | 1.2 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.2 | 2.3 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 | 0.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 10.1 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.2 | 0.6 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.2 | 3.3 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.2 | 2.7 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.2 | 0.6 | GO:0051659 | maintenance of mitochondrion location(GO:0051659) |
0.2 | 3.0 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.2 | 0.6 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.2 | 0.4 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.2 | 0.6 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.2 | 1.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.2 | 0.8 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.2 | 1.4 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.2 | 0.2 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.2 | 1.4 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.2 | 1.6 | GO:0009313 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
0.2 | 0.6 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.2 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 1.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.6 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.2 | 2.3 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.2 | 0.6 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.2 | 0.6 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.2 | 1.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.8 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 3.7 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.2 | 1.5 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.2 | 1.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 2.2 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 0.9 | GO:0003322 | pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) sensory neuron migration(GO:1904937) |
0.2 | 2.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 0.4 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.2 | 0.9 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.2 | 0.4 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.2 | 0.6 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.2 | 0.4 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.2 | 1.1 | GO:1903273 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
0.2 | 0.9 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.2 | 1.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 1.8 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 1.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 0.2 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.2 | 1.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 0.9 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
0.2 | 0.3 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.2 | 0.7 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.2 | 1.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 0.9 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.2 | 0.8 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.2 | 1.3 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 0.8 | GO:0014042 | positive regulation of mitochondrial fusion(GO:0010636) positive regulation of neuron maturation(GO:0014042) |
0.2 | 3.1 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.2 | 0.5 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 0.8 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.2 | 0.3 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 1.6 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 0.5 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.2 | 1.0 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 3.8 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 0.3 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.2 | 0.5 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.2 | 0.6 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
0.2 | 0.5 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.2 | 0.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.2 | 1.9 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 0.5 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
0.2 | 0.5 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.2 | 2.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 2.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 1.2 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.2 | 0.9 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.2 | 1.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 0.5 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.2 | 6.8 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 1.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 1.0 | GO:1904478 | regulation of intestinal absorption(GO:1904478) |
0.1 | 0.4 | GO:0097534 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.1 | 0.6 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 1.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.4 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.1 | 0.3 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 2.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 1.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 3.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 2.0 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.1 | 0.7 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 1.7 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.3 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.1 | 0.4 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) |
0.1 | 0.7 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 3.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.4 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 3.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.4 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
0.1 | 1.0 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.1 | 0.4 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.4 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.7 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 5.6 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.7 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.1 | 1.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.5 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.1 | 0.5 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 2.1 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.7 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 1.4 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.5 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.5 | GO:0030026 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
0.1 | 0.3 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.3 | GO:0050973 | detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
0.1 | 0.3 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 0.1 | GO:0060061 | Spemann organizer formation(GO:0060061) canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
0.1 | 1.2 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.7 | GO:0070836 | caveola assembly(GO:0070836) |
0.1 | 0.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 1.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 1.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 2.1 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 1.4 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
0.1 | 1.0 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 1.2 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.6 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 1.7 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.7 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 1.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 1.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.6 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.1 | 0.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 3.3 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.8 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 1.8 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.1 | 0.8 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.5 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.1 | 3.2 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.8 | GO:0051189 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.5 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 1.1 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 0.1 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.1 | 0.7 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.1 | 0.6 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.8 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.7 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.1 | 0.2 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.1 | 0.3 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.1 | 0.6 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.1 | 0.3 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) negative regulation of histone phosphorylation(GO:0033128) |
0.1 | 0.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 1.3 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.1 | 0.7 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.1 | 0.4 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.1 | 1.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.7 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.1 | 0.8 | GO:1902548 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.1 | 0.4 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.1 | 0.4 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.1 | 0.4 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.8 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.6 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.1 | 0.4 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.1 | 0.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.6 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.1 | 0.8 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.1 | 1.0 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 1.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 3.8 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 1.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.9 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 1.2 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 0.4 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.1 | 0.7 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.7 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 1.6 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 0.8 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.8 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.1 | 0.8 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.4 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.1 | 0.3 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 1.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 1.6 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 1.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.8 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.4 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.1 | 0.5 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.1 | 0.8 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 1.1 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.2 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.9 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 0.6 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.6 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.3 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 1.4 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 2.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 1.8 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.3 | GO:0015800 | acidic amino acid transport(GO:0015800) |
0.1 | 0.5 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.2 | GO:0033505 | ventral midline development(GO:0007418) floor plate formation(GO:0021508) floor plate morphogenesis(GO:0033505) |
0.1 | 0.3 | GO:2000812 | response to rapamycin(GO:1901355) regulation of barbed-end actin filament capping(GO:2000812) |
0.1 | 0.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 1.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.6 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 4.5 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 0.3 | GO:0045358 | negative regulation of interferon-beta biosynthetic process(GO:0045358) |
0.1 | 1.1 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 0.5 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 1.6 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 | 0.3 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.1 | 1.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 1.2 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.2 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.1 | 0.5 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.1 | 0.6 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 1.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 3.3 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.4 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.1 | 0.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 1.6 | GO:0015918 | sterol transport(GO:0015918) |
0.1 | 0.6 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.8 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.5 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.1 | 0.4 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.1 | 0.8 | GO:0033866 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.5 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 1.2 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 0.3 | GO:1904752 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.1 | 0.2 | GO:0002352 | B cell negative selection(GO:0002352) |
0.1 | 0.4 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 1.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 1.0 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.1 | 0.5 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.1 | 0.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.9 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.4 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 0.3 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.2 | GO:0099552 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.1 | 0.6 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.6 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 1.0 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.3 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 2.4 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.2 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.1 | 0.8 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 1.5 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.4 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 2.5 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.2 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.1 | 4.1 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 0.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 0.4 | GO:0015692 | vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) ferrous iron import(GO:0070627) |
0.1 | 1.3 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.7 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.1 | 0.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 3.5 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.1 | 0.3 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.6 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 0.3 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.3 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.1 | 0.3 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 0.5 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.3 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
0.1 | 0.9 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 1.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 2.1 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.1 | 0.6 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.8 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 2.3 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 4.3 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.5 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.2 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.1 | 0.4 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.2 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
0.1 | 0.6 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 2.1 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.6 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.8 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 0.3 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.5 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 0.2 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.1 | 0.3 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 0.8 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.4 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 3.0 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 0.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 1.0 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.3 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.5 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 0.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.4 | GO:0043585 | nose morphogenesis(GO:0043585) alveolar primary septum development(GO:0061143) |
0.1 | 0.7 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 0.9 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 0.3 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.1 | 0.9 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.5 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.2 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.5 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 0.4 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.1 | 0.8 | GO:0042438 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.1 | 0.2 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.2 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.1 | 0.4 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.6 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 1.0 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.2 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.1 | 2.4 | GO:0032835 | glomerulus development(GO:0032835) |
0.1 | 0.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.7 | GO:0030325 | adrenal gland development(GO:0030325) |
0.1 | 0.6 | GO:0033753 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.1 | 0.5 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 0.2 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.1 | 1.2 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.1 | 0.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.5 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.1 | 0.3 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.2 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
0.1 | 0.5 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.8 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.1 | 0.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.5 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.0 | 0.4 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.0 | 1.8 | GO:1902652 | cholesterol metabolic process(GO:0008203) secondary alcohol metabolic process(GO:1902652) |
0.0 | 0.1 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
0.0 | 1.9 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.0 | 0.1 | GO:0061518 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) |
0.0 | 0.7 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.8 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.5 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.6 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 1.1 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.0 | 0.7 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.7 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.7 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.0 | 0.2 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.3 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.2 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 0.2 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.0 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.9 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.4 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.2 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.0 | 5.0 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.3 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.0 | 0.6 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.0 | 0.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.2 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.3 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.0 | 0.7 | GO:0097352 | autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
0.0 | 0.9 | GO:0007041 | lysosomal transport(GO:0007041) |
0.0 | 0.6 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.3 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.4 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 1.0 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.5 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.6 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.0 | 0.9 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.2 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.5 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.9 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 1.8 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.5 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.0 | 0.4 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.4 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.0 | 0.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 1.2 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.0 | GO:1900222 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) very-low-density lipoprotein particle clearance(GO:0034447) negative regulation of beta-amyloid clearance(GO:1900222) |
0.0 | 0.6 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.0 | 0.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.2 | GO:0060406 | regulation of penile erection(GO:0060405) positive regulation of penile erection(GO:0060406) |
0.0 | 1.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.1 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
0.0 | 0.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.3 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.0 | 0.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.2 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.0 | 0.2 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
0.0 | 1.3 | GO:0006818 | hydrogen transport(GO:0006818) |
0.0 | 0.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 6.2 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.0 | 0.2 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.0 | 0.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.1 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.4 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 1.6 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.0 | 0.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.2 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.5 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.1 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.0 | 0.6 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.0 | 1.1 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.0 | 0.2 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.1 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.0 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.4 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.1 | GO:0060677 | ureteric bud elongation(GO:0060677) ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.0 | 1.0 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
0.0 | 0.8 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.0 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.6 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 1.8 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.2 | GO:0070166 | enamel mineralization(GO:0070166) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 1.2 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.0 | 0.1 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
0.0 | 0.2 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.0 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.5 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
0.0 | 0.7 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 0.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.2 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 1.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.3 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.2 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.1 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.3 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.3 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.1 | GO:1900247 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) positive regulation of mRNA polyadenylation(GO:1900365) |
0.0 | 0.4 | GO:0060008 | Sertoli cell differentiation(GO:0060008) Sertoli cell development(GO:0060009) |
0.0 | 0.1 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.0 | 1.1 | GO:0048477 | oogenesis(GO:0048477) |
0.0 | 0.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.5 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.5 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.2 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.0 | 0.1 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.0 | 0.3 | GO:0009299 | mRNA transcription(GO:0009299) |
0.0 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.1 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 0.6 | GO:0036503 | ERAD pathway(GO:0036503) |
0.0 | 0.3 | GO:0043486 | histone exchange(GO:0043486) |
0.0 | 0.2 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.2 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.4 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.3 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.2 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.0 | 0.1 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.0 | 0.1 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.0 | 0.2 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.0 | 0.2 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.2 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.0 | 0.2 | GO:0043574 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 | 0.2 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.1 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 2.2 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.3 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.0 | 0.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.0 | 0.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.2 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.0 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
0.0 | 0.2 | GO:0019217 | regulation of fatty acid metabolic process(GO:0019217) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.1 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.0 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.0 | 0.3 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.0 | 0.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 11.6 | GO:0042567 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) insulin-like growth factor ternary complex(GO:0042567) |
1.3 | 14.1 | GO:0005579 | membrane attack complex(GO:0005579) |
1.1 | 4.4 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
1.1 | 5.4 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.8 | 2.4 | GO:0005713 | recombination nodule(GO:0005713) |
0.8 | 6.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.8 | 12.0 | GO:0045180 | basal cortex(GO:0045180) |
0.7 | 4.4 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.7 | 7.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.6 | 5.3 | GO:0030478 | actin cap(GO:0030478) |
0.6 | 2.9 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.6 | 2.3 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.6 | 2.8 | GO:0030891 | VCB complex(GO:0030891) |
0.5 | 1.6 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.5 | 2.0 | GO:0097447 | dendritic tree(GO:0097447) |
0.5 | 1.0 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.4 | 0.4 | GO:0098803 | respiratory chain complex(GO:0098803) |
0.4 | 9.8 | GO:0043196 | varicosity(GO:0043196) |
0.4 | 2.0 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.4 | 1.9 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.4 | 3.0 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.3 | 2.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 2.0 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.3 | 1.6 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.3 | 11.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.3 | 2.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.3 | 1.9 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.3 | 6.9 | GO:0034706 | sodium channel complex(GO:0034706) |
0.3 | 2.0 | GO:0097441 | basilar dendrite(GO:0097441) |
0.3 | 0.3 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.3 | 3.4 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.3 | 1.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.3 | 5.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.3 | 2.8 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.3 | 3.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 2.7 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 1.7 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 0.4 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 6.7 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 1.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 1.7 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 2.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 0.6 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.2 | 1.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 0.6 | GO:0044308 | axonal spine(GO:0044308) |
0.2 | 1.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 1.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.2 | 1.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 3.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 0.6 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.2 | 9.0 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 0.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 1.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 2.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 0.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.2 | 1.6 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 0.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 2.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 2.9 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 4.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 0.2 | GO:0097361 | CIA complex(GO:0097361) |
0.2 | 0.8 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.2 | 3.2 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.2 | 1.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 1.1 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 1.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 2.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 1.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 2.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 1.7 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.8 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 1.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 30.2 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 4.7 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 1.6 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.1 | 0.5 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 4.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.5 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 0.4 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.1 | 3.8 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.1 | 1.0 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 1.8 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 1.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.7 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 0.7 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.1 | 0.7 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 0.7 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 1.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 1.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 1.0 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.6 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.3 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.1 | 0.6 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.9 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 4.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 1.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 1.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.9 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 1.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.5 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 0.3 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 1.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.4 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 2.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 1.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.4 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.1 | 0.8 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 1.9 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.3 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.1 | 0.3 | GO:0098830 | presynaptic endosome(GO:0098830) |
0.1 | 0.8 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.7 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.5 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 2.3 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.7 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.1 | 0.9 | GO:0002177 | manchette(GO:0002177) |
0.1 | 2.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.3 | GO:0098855 | HCN channel complex(GO:0098855) |
0.1 | 32.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.5 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.5 | GO:0000235 | astral microtubule(GO:0000235) |
0.1 | 0.7 | GO:0045252 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.3 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.7 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.1 | 0.3 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.1 | 0.4 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.6 | GO:0001652 | granular component(GO:0001652) |
0.1 | 1.6 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.1 | 0.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 1.3 | GO:0097386 | glial cell projection(GO:0097386) |
0.1 | 0.7 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 1.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 1.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.4 | GO:0070826 | paraferritin complex(GO:0070826) |
0.1 | 0.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 3.7 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.3 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.1 | 0.3 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 0.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.4 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 1.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 1.9 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 12.7 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.7 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 4.5 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 1.6 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.3 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 1.3 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 2.1 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 1.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.2 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 1.4 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.4 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 0.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.9 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.4 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 2.0 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.8 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.0 | 2.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.3 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 2.4 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.0 | 0.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 0.1 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.0 | 0.9 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.4 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.0 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 0.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 0.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 2.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0044305 | calyx of Held(GO:0044305) presynaptic active zone cytoplasmic component(GO:0098831) |
0.0 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 6.3 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 1.4 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 5.3 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.5 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.3 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 7.6 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 5.6 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 1.7 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 3.2 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 2.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 3.7 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.3 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.3 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 2.2 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.0 | 0.1 | GO:0034448 | EGO complex(GO:0034448) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 2.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 2.4 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 0.0 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
0.0 | 4.6 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.0 | 0.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 1.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.7 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.8 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.2 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.1 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.0 | 1.3 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.6 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.3 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.0 | 0.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.1 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.0 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 5.2 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 19.3 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.5 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.3 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 1.2 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.5 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.2 | GO:0090544 | BAF-type complex(GO:0090544) |
0.0 | 0.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 9.8 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 13.8 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
2.9 | 8.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
2.1 | 12.7 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
1.6 | 6.5 | GO:0004058 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
1.6 | 8.1 | GO:0004925 | prolactin receptor activity(GO:0004925) |
1.3 | 5.3 | GO:0004096 | catalase activity(GO:0004096) |
1.2 | 4.8 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
1.2 | 3.6 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.1 | 16.9 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.1 | 1.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.1 | 2.1 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
1.0 | 6.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
1.0 | 4.0 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.0 | 4.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.9 | 4.7 | GO:0008142 | oxysterol binding(GO:0008142) |
0.9 | 9.9 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.9 | 2.6 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.9 | 1.7 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.8 | 2.5 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.7 | 4.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.7 | 27.2 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.7 | 3.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.7 | 7.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.7 | 4.0 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.6 | 2.6 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.6 | 3.8 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.6 | 3.2 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.6 | 8.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.6 | 1.9 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.6 | 3.7 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.6 | 2.4 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.6 | 2.9 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.6 | 5.7 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.6 | 2.3 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.6 | 2.3 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.6 | 11.6 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.5 | 3.2 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.5 | 2.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.5 | 2.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.5 | 2.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.5 | 3.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.5 | 3.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.5 | 1.5 | GO:0080122 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.5 | 1.9 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.5 | 0.5 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.5 | 1.4 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.5 | 1.4 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.5 | 1.4 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.5 | 1.4 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.4 | 1.3 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.4 | 4.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.4 | 1.3 | GO:0018738 | S-formylglutathione hydrolase activity(GO:0018738) |
0.4 | 1.7 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.4 | 1.7 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
0.4 | 1.6 | GO:0070279 | vitamin B6 binding(GO:0070279) |
0.4 | 1.2 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.4 | 1.2 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.4 | 1.2 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
0.4 | 8.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.4 | 2.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.4 | 1.6 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.4 | 1.6 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.4 | 1.6 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.4 | 1.9 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.4 | 1.9 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.4 | 1.9 | GO:0070287 | ferritin receptor activity(GO:0070287) |
0.4 | 1.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.4 | 2.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.4 | 1.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.4 | 1.1 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.4 | 1.1 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.3 | 1.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 2.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.3 | 1.0 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) |
0.3 | 2.0 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.3 | 1.9 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 2.2 | GO:0031404 | alpha-amylase activity(GO:0004556) chloride ion binding(GO:0031404) |
0.3 | 1.3 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.3 | 1.6 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 0.9 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.3 | 0.9 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.3 | 0.9 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.3 | 2.7 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 1.5 | GO:0032810 | sterol response element binding(GO:0032810) |
0.3 | 0.3 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
0.3 | 0.9 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.3 | 2.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 2.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.3 | 0.8 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.3 | 1.1 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.3 | 2.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 1.9 | GO:0089720 | caspase binding(GO:0089720) |
0.3 | 0.8 | GO:0030614 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.3 | 0.8 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 0.8 | GO:0070540 | stearic acid binding(GO:0070540) |
0.3 | 1.3 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.3 | 1.0 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.3 | 0.8 | GO:0016824 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
0.3 | 3.0 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 1.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 1.7 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.2 | 5.8 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 7.8 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 1.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 2.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 1.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 1.8 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.2 | 2.0 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 0.9 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.2 | 0.7 | GO:0050145 | uridylate kinase activity(GO:0009041) nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 0.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 2.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 5.7 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.2 | 1.5 | GO:0016405 | CoA-ligase activity(GO:0016405) |
0.2 | 1.7 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.2 | 0.6 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.2 | 1.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 7.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 0.6 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.2 | 0.8 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.2 | 1.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 0.8 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.2 | 2.1 | GO:0035473 | lipase binding(GO:0035473) |
0.2 | 5.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 1.2 | GO:0004103 | choline kinase activity(GO:0004103) |
0.2 | 2.0 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 2.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 2.6 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.2 | 0.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.2 | 1.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 0.4 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.2 | 0.6 | GO:0004335 | galactokinase activity(GO:0004335) |
0.2 | 4.2 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 1.4 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.2 | 7.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 0.8 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.2 | 1.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.2 | 4.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 2.2 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 1.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 0.9 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.2 | 0.7 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.2 | 0.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 0.5 | GO:0005118 | sevenless binding(GO:0005118) |
0.2 | 1.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 0.9 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 2.7 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 1.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 6.7 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 2.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 0.5 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.2 | 1.9 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.2 | 0.8 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.2 | 0.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 3.3 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.2 | 1.8 | GO:0051870 | methotrexate binding(GO:0051870) |
0.2 | 0.8 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 0.7 | GO:0055105 | ubiquitin-protein transferase inhibitor activity(GO:0055105) |
0.2 | 0.5 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.2 | 1.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.7 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.2 | 2.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 1.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 0.6 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.2 | 3.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.2 | 0.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 0.5 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.2 | 0.9 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.2 | 2.0 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 3.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 0.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 0.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.9 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 4.7 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 0.6 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 1.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 1.0 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 4.1 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 0.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.7 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.6 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.4 | GO:0008158 | smoothened binding(GO:0005119) hedgehog receptor activity(GO:0008158) |
0.1 | 1.7 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 1.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.7 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.8 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 0.5 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 3.9 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.7 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 2.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 2.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.4 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 0.7 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.1 | 0.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.9 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.1 | 0.5 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.1 | 0.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 1.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.8 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 1.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.7 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 2.6 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 1.0 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 2.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 0.4 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
0.1 | 2.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 4.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 1.4 | GO:0043855 | cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.5 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 1.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 1.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.7 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.1 | 0.9 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 1.4 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.1 | 1.7 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 1.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.6 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 4.5 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 0.4 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
0.1 | 0.5 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 2.9 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 1.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.7 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.5 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.1 | 2.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 1.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.4 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.1 | 0.5 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) |
0.1 | 0.5 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 1.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 2.6 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 1.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 1.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.6 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.1 | 0.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.3 | GO:0030338 | CMP-N-acetylneuraminate monooxygenase activity(GO:0030338) |
0.1 | 0.3 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.1 | 1.0 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.7 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 1.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 10.5 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.1 | 1.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.1 | 2.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 10.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 1.8 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 3.2 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.1 | 0.7 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.5 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.6 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.8 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.2 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.1 | 0.2 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
0.1 | 0.2 | GO:0047874 | dolichyldiphosphatase activity(GO:0047874) |
0.1 | 0.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 1.0 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 1.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.4 | GO:0015639 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.1 | 0.5 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.2 | GO:0043532 | angiostatin binding(GO:0043532) |
0.1 | 1.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 1.8 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 1.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.2 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 1.3 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 1.8 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.9 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.8 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.2 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.1 | 1.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 1.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 1.1 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 0.6 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 1.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.7 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.3 | GO:0001093 | TFIIB-class transcription factor binding(GO:0001093) |
0.1 | 0.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.3 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.1 | 1.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.9 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 1.4 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 2.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.6 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 1.5 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.2 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.0 | 0.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.2 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.6 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.9 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 1.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.3 | GO:0016934 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.2 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 3.6 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 0.5 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.9 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.8 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 0.2 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 1.3 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 1.0 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.2 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.1 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.0 | 0.2 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.0 | 0.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 1.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.2 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
0.0 | 0.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.4 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 2.2 | GO:0005253 | anion channel activity(GO:0005253) |
0.0 | 1.4 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 2.1 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.0 | 0.7 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 1.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.2 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.0 | 0.9 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 3.4 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.4 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.7 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 1.0 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.1 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.0 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 0.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 1.4 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 0.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 1.8 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.2 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 0.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0032029 | myosin tail binding(GO:0032029) |
0.0 | 0.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.9 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.5 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 3.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 5.3 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 1.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.4 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.2 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 3.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 1.6 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.3 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 1.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.0 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 1.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 0.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 1.0 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.0 | 0.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.0 | GO:0008948 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
0.0 | 0.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.6 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.3 | GO:0050661 | NADP binding(GO:0050661) |
0.0 | 0.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.0 | 0.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.2 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.3 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.0 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.0 | 0.0 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.0 | 0.1 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.0 | 0.3 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 16.9 | PID IGF1 PATHWAY | IGF1 pathway |
0.3 | 20.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 9.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 12.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 7.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 8.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 8.8 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 5.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 7.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 2.6 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 2.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 6.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 6.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 3.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 4.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 1.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 1.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 1.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 1.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 1.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 1.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.7 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 1.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 1.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.9 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 1.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 1.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 1.1 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.6 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 8.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.6 | 2.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.6 | 10.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.5 | 17.9 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.5 | 1.5 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.4 | 5.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 3.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.4 | 14.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.4 | 5.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.4 | 9.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 7.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.3 | 4.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 3.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 5.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.3 | 27.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 4.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.3 | 5.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 9.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 5.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 6.0 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.2 | 0.7 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.2 | 5.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 6.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 2.6 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.2 | 3.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 3.0 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 2.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 5.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 3.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 4.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 3.9 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 2.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 1.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 7.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 3.4 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 4.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 2.6 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 1.6 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 3.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 8.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 3.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 4.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 21.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 3.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 4.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.6 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.1 | 0.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 3.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 1.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 4.0 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 2.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.7 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.7 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 1.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 1.9 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 0.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 2.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 4.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 5.0 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.9 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 2.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 1.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 0.7 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 2.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 1.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.7 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 1.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 0.1 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 0.3 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.1 | 1.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 1.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 1.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.7 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 0.3 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 1.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.8 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 1.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.2 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 0.9 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.6 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 1.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 1.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.5 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 1.0 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.0 | 0.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 1.5 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.3 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.0 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |